The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...

February is American Heart Month. The goal is raising awareness that heart disease is the leading cause of death in the US, ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides interventional cardiologists, cardiothoracic surgeons, and heart teams with ...

The UHS Heart & Vascular Institute recently celebrated a significant milestone with the completion of their 1,000th TAVR (Transcatheter Aortic Valve Replacement) procedure. This achievement is ...

Zovighian said the transition to CEO has been relatively smooth since he joined Edwards in 2015 and spent eight years in ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this year.

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

Discover how recent advancements in cardiovascular medicine, including TAVI and TEER, are revolutionizing heart disease ...

Pete Furnbaugh: First of all, the Tavr procedure. We’re at how many procedures now that you’ve done? Dr. Tristan Smith: So, here we’ve done close to 225. Before this, where we were before ...

Stifel upgrades Edwards Lifesciences to Buy, citing TAVR growth potential and FDA label expansion in 2025. Edwards' Critical Care sale and focus on structural heart could drive higher valuation ...

Within the Transcatheter Aortic Valve Replacement (TAVR) arm, Edwards Lifesciences is likely to have witnessed continued growth in procedures across the United States and worldwide. Continued ...